Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Cold Spring Harbor Laboratory is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are split between 2 distinct examiners and 2 distinct art units. This indicates that each of the 2 pending office actions is being examined independently in different technical groups. There is no overlap between the 2 distinct examiners or the 2 distinct art units for the company's current workload.
OLSON, ALEXANDRA NADINE is the busiest examiner for the company, holding 1 busiest examiner pending office action. This examiner is responsible for half of the 2 pending office actions currently active. The other half is handled by the second of the 2 distinct examiners. This distribution ensures that the company's 2 pending office actions are subject to two different perspectives, as no single examiner has a dominant role in the prosecution.
For a patent practitioner, this distribution across 2 distinct art units and 2 distinct examiners within Biotechnology & Pharmaceuticals means that each case must be prosecuted on its own merits. The lack of overlap among the 2 distinct examiners and 2 distinct art units requires a strategy that addresses the specific technical nuances of each of the 2 pending office actions independently. Maintaining consistency across the 2 pending office actions is essential, even though they are being reviewed by 2 distinct examiners in 2 distinct art units.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §103 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ALEXANDRA NADINE | 1 | 100.0% | +0.0% |
| IANNUZO, NATALIE NMN | 1 | 12.2% | +71.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18690018 | METHOD OF MEASURING MICROSATELLITE LENGTH VARIATIONS | OLSON, ALEXANDRA NADINE | — |
| 17532123 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | IANNUZO, NATALIE NMN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17532123 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | IANNUZO, NATALIE NMN | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18690018 | METHOD OF MEASURING MICROSATELLITE LENGTH VARIATIONS | OLSON, ALEXANDRA NADINE | 1637 | §101§103§112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 17532123 | COMPOSITIONS AND METHODS FOR HEMOGLOBIN PRODUCTION | IANNUZO, NATALIE NMN | 1653 | §103 | Non-Final OA | — | Pending | Nov 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCold Spring Harbor Laboratory has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Alexandra Nadine Olson has the most, with 1 of Cold Spring Harbor Laboratory's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
